A revolution in the field of regenerative medicine
3D bioprint technology has been used for the construction of functional human tissues and three-dimensional in vitro models, starting from the impression of cells loaded in polymer matrices that are positioned layer-by- layer in a programmed and hierarchical way.
3D bioprinting impacts on many activities and sectors, for example:
Pharmaceutical and cosmetic industry:
The major challenge of the pharmaceutical and cosmetic industry is to find alternatives and solutions for preclinical drug testing and formulations before they are released. There are no good preclinical models that say a new drug is effective and safe to go on to clinical trials. The use of animal models is increasingly contradictory, since these tests deal with ethical issues, as well as high cost and relevance for human risk assessment. In addition, there is a growing idea that in vitro approaches can eliminate these problems without impairing human safety because of the repeatability standards that biopranders can achieve.
With the use of 3D bioprinting there are more possibilities for conducting tests in research and development activities.
3D bioprinting has caused enthusiasm in the field of regenerative medicine. The prospect is that in the medium term, 5 to 10 years, it will be possible to give surgeons printed fabrics that meet specific demands, from skin tissue, cartilage, bone, to vascular grafts and more complex organs.
Bioprinting, 3DBS and the Future:
The flexibility of our bioprinting technology and its application in a wide variety of cells allows us to envision the delivery of various types of tissue using or not the patient’s own cells, reducing rejections and the need for immunosuppressive drugs as well as transplantation lines.